ReqMed Company

Executive Summary

ReqMed Company is a Japanese medtech startup (founded 2020, 10-50 employees) specializing in diagnostic solutions and medical devices. The company develops innovative tools aimed at improving clinical decision-making and patient monitoring, primarily serving the Japanese healthcare market. With a focus on technology-driven diagnostics, ReqMed seeks to address unmet needs in early disease detection and precision medicine. The company operates in a growing niche within Japan's aging population demographic, which demands advanced diagnostic capabilities. Despite being in the platform stage, ReqMed has not disclosed funding rounds or valuation, suggesting it may be bootstrapped or in early fundraising discussions. The lack of public product approvals or commercial products indicates that the company is likely in development or regulatory preparation phase. Its compact team size and Tokyo location position it well within Japan's medical technology ecosystem, which benefits from strong government support for healthcare innovation. However, the absence of revenue, partnerships, or clinical data makes it challenging to assess competitive positioning. The company's success hinges on securing regulatory clearance from Japan's PMDA, forming strategic alliances with hospital networks, and differentiating its diagnostic platforms against established players. The limited publicly available information results in a moderate conviction score.

Upcoming Catalysts (preview)

• Q3 2026PMDA regulatory submission for a flagship diagnostic device60% success
• Q4 2026Series A funding round announcement70% success
• H2 2026Partnership with a major Japanese hospital network for clinical trials50% success